Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Triamcinolone Acetonide × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Lymphoid 1 Genitourinary 1 Dermatologic 1 CNS 1 Breast 1

Conditions

Lung Neoplasms 1 Exanthema 1

Interventions

Carboplatin 542 Pemetrexed 399 Cisplatin 396 Paclitaxel 271 Docetaxel 254 Gemcitabine 217 pembrolizumab 190 Bevacizumab 190 Erlotinib Hydrochloride 184 Radiotherapy 178 Etoposide 144 durvalumab 139 Nivolumab 132 Drug Therapy 123 osimertinib 106 atezolizumab 92 Gefitinib 74 Radiosurgery 71 Vinorelbine 68 anlotinib 66 Irinotecan 51 tislelizumab 50 Ipilimumab 49 130-nm albumin-bound paclitaxel 49 Taxes 47 Surgical Procedures, Operative 46 sintilimab 44 apatinib 44 Cetuximab 44 Albumin-Bound Paclitaxel 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00473083 2017-04-04

LUTRAERL

British Columbia Cancer Agency

Phase 2 Completed

150 enrolled 13 charts

Exanthema, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡